Objective
This study evaluates the impact of an integrated Behavioral Health Home (BHH) pilot for adults with psychotic and bipolar disorders.
Methods
Quasi-experimental methods were used to compare outcomes pre- (September 2014 to August 2015) and post-intervention (September 2015 to August 2016) among ambulatory BHH participants and non-participants. Electronic health records of 424 BHH participants (369 with a psychotic disorder; 55 with bipolar disorder) were compared with 1521 individuals not in the BHH from an urban, safety-net health system. Groups were propensity score-weighted by sex, age, race/ethnicity, language, 2010 Census block group demographics, Medicare and Medicaid enrollment, and diabetes diagnosis.
Results
BHH participants had fewer total psychiatric inpatient (IP) visits and fewer total ED visits compared to non-BHH patients, which was predominantly driven by the smaller number of visits among BHH participants with ≥1 visit. There were no differences in medical hospitalizations. While BHH participants were more likely to receive HbA1c screening, there were no differences in lipid monitoring. Regarding secondary outcomes, there were no significant differences in changes in metabolic monitoring parameters among patients with diabetes.
Conclusions
Participation in a pilot ambulatory BHH program was associated with significant reductions in ED visits and psychiatric hospitalizations, and increased HbA1c monitoring, among patients with psychotic and bipolar disorders. Longer-term evaluation is needed to assess impact on care processes and population health outcomes. This evaluation builds on prior research by specifying intervention details and the clinical target population, strengthening the evidence base for care integration to support further program dissemination.